The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cytotoxicity and slow release of the anti-cancer drug doxorubicin from ZIF-8
Open accessAbstract
Metal–organic frameworks are emerging as a powerful platform for the delivery and controlled release of several drug molecules. Herein, we report the incorporation of the anti-cancer drug doxorubicin into the zeolitic imidazolate framework (ZIF-8) with high-load and progressive release. Adsorption measurements show that doxorubicin is incorporated into ZIF-8 with a load of 0.049 g doxorubicin g−1 dehydrated ZIF-8. Doxorubicin is released in a highly controlled and progressive fashion with 66% of the drug released after 30 days. We also characterize the antitumoral potential and cytotoxicity of the doxorubicin-ZIF-8 (DOXO-ZIF-8) complex towards the mucoepidermoid carcinoma of human lung (NCI-H292), human colorectal adenocarcinoma (HT-29), and human promyelocytic leukemia (HL-60) cell lines. It is shown that the complex doxorubicin-ZIF-8 exhibits lower cytotoxicity than pure doxorubicin for the tested cells, possibly due to the slower release of the incorporated drug. Furthermore, host–guest interactions have been addressed from a microscopic perspective through molecular docking simulations. In conjunction with our experimental characterization, the calculations suggest that doxorubicin binds preferentially to the surface rather than into the pores of ZIF-8, whose entry diameter is at least half the size of the shortest axis of the drug. These findings are also consistent with high-resolution X-ray crystallography and NMR spectroscopy studies of ZIF-8 which shows that this framework is very rigid under constant pressure in contrast to previous experimental and theoretical studies of ZIF-8 under gas pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
A profile refinement method for nuclear and magnetic structures
Rietveld, H. M. (1969) · Journal of Applied Crystallography · doi:10.1107/s0021889869006558 · Cited by 17,524
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
EXPGUI, a graphical user interface for GSAS
Toby, B. H. (2001) · Journal of Applied Crystallography · doi:10.1107/s0021889801002242 · Cited by 9,247
Reticular synthesis and the design of new materials
Yaghi, O. M., O'Keeffe, M., Ockwig, N. W., Chae, H. K., Eddaoudi, M., & Kim, J. (2003) · Nature · doi:10.1038/nature01650 · Cited by 9,101
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Design and synthesis of an exceptionally stable and highly porous metal-organic framework
Li, H., Eddaoudi, M., O'Keeffe, M., & Yaghi, O. M. (1999) · Nature · doi:10.1038/46248 · Cited by 8,554
Exceptional chemical and thermal stability of zeolitic imidazolate frameworks
Park, K. S., Ni, Z., Côté, A. P., Choi, J. Y., Huang, R., Uribe-Romo, F. J., Chae, H. K., O’Keeffe, M., & Yaghi, O. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602439103 · Cited by 7,563
NWChem: A comprehensive and scalable open-source solution for large scale molecular simulations
Valiev, M., Bylaska, E. J., Govind, N., Kowalski, K., Straatsma, T. P., Van Dam, H. J. J., Wang, D., Nieplocha, J., Apra, E., Windus, T. L., et al. (2010) · Computer Physics Communications · doi:10.1016/j.cpc.2010.04.018 · Cited by 5,779
Cited by
Zheng, H., Zhang, Y., Liu, L., Wan, W., Guo, P., Nyström, A. M., & Zou, X. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b11720 · Cited by 1,383
Zeolitic imidazolate framework materials: recent progress in synthesis and applications
Chen, B., Yang, Z., Zhu, Y., & Xia, Y. (2014) · J. Mater. Chem. A · doi:10.1039/c4ta02984d · Cited by 1,009
He, C., Liu, D., & Lin, W. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00125 · Cited by 1,001
Metal–Organic Frameworks for Drug Delivery: A Design Perspective
Lawson, H. D., Walton, S. P., & Chan, C. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01089 · Cited by 916
Characterization and properties of Zn/Co zeolitic imidazolate frameworks vs. ZIF-8 and ZIF-67
Zhou, K., Mousavi, B., Luo, Z., Phatanasri, S., Chaemchuen, S., & Verpoort, F. (2017) · Journal of Materials Chemistry A · doi:10.1039/c6ta07860e · Cited by 778
Metal–Organic Framework Nanocarriers for Drug Delivery in Biomedical Applications
Sun, Y., Zheng, L., Yang, Y., Qian, X., Fu, T., Li, X., Yang, Z., Yan, H., Cui, C., & Tan, W. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00423-3 · Cited by 723
Recent Advances in Metal Decorated Nanomaterials and Their Various Biological Applications: A Review
Yaqoob, A. A., Ahmad, H., Parveen, T., Ahmad, A., Oves, M., Ismail, I. M. I., Qari, H. A., Umar, K., & Mohamad Ibrahim, M. N. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00341 · Cited by 718
Nanoparticles of Metal‐Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine
Simon‐Yarza, T., Mielcarek, A., Couvreur, P., & Serre, C. (2018) · Advanced Materials · doi:10.1002/adma.201707365 · Cited by 648
Nanostructured metal–organic frameworks and their bio-related applications
Giménez-Marqués, M., Hidalgo, T., Serre, C., & Horcajada, P. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.08.008 · Cited by 574
Photocatalytic degradation of methylene blue in ZIF-8
Jing, H.-P., Wang, C.-C., Zhang, Y.-W., Wang, P., & Li, R. (2014) · RSC Adv. · doi:10.1039/c4ra08820d · Cited by 568
Metal–Organic Framework‐Based Nanomedicine Platforms for Drug Delivery and Molecular Imaging
Cai, W., Chu, C., Liu, G., & Wáng, Y. J. (2015) · Small · doi:10.1002/smll.201500802 · Cited by 456
Synthesis and modification of ZIF-8 and its application in drug delivery and tumor therapy
Wang, Q., Sun, Y., Li, S., Zhang, P., & Yao, Q. (2020) · RSC Advances · doi:10.1039/d0ra07950b · Cited by 399
Biocompatibility characteristics of the metal organic framework ZIF-8 for therapeutical applications
Hoop, M., Walde, C. F., Riccò, R., Mushtaq, F., Terzopoulou, A., Chen, X.-Z., deMello, A. J., Doonan, C. J., Falcaro, P., Nelson, B. J., et al. (2018) · Applied Materials Today · doi:10.1016/j.apmt.2017.12.014 · Cited by 345
Ruyra, À., Yazdi, A., Espín, J., Carné‐Sánchez, A., Roher, N., Lorenzo, J., Imaz, I., & Maspoch, D. (2015) · Chemistry – A European Journal · doi:10.1002/chem.201405380 · Cited by 299
Metal–Organic Frameworks for Cell and Virus Biology: A Perspective
Riccò, R., Liang, W., Li, S., Gassensmith, J. J., Caruso, F., Doonan, C., & Falcaro, P. (2018) · ACS Nano · doi:10.1021/acsnano.7b08056 · Cited by 293
Wu, Q., Niu, M., Chen, X., Tan, L., Fu, C., Ren, X., Ren, J., Li, L., Xu, K., Zhong, H., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.022 · Cited by 289
Ren, H., Zhang, L., An, J., Wang, T., Li, L., Si, X., He, L., Wu, X., Wang, C., & Su, Z. (2014) · Chem. Commun. · doi:10.1039/c3cc47666a · Cited by 271
Zhang, H., Jiang, W., Liu, R., Zhang, J., Zhang, D., Li, Z., & Luan, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b05142 · Cited by 253
Advances in immunomodulatory MOFs for biomedical applications
Zhang, B., Chen, J., Zhu, Z., Zhang, X., & Wang, J. (2024) · Small · doi:10.1002/smll.202307299 · Cited by 31
Metadata
- Authors
- Vasconcelos, I. B., Silva, T. G. D., Militão, G. C. G., Soares, T. A., Rodrigues, N. M., Rodrigues, M. O., Costa, N. B. D., Freire, R. O., & Junior, S. A.
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2012
- Volume
- 2
- Issue
- 25
- Pages
- 9437
- ISSN
- 2046-2069 (ISSN-L)
- OpenAlex
- W1998358059
- Cited by
- 311
- References
- 42
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.